Page last updated: 2024-12-08
conopressin g
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
conopressin G: amino acid sequence given in first source; molluscan vasopressin-like peptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 163847 |
SCHEMBL ID | 15511399 |
MeSH ID | M0205993 |
Synonyms (10)
Synonym |
---|
conopressin g |
111317-91-0 |
(2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2s)-butan-2-yl]-10-[3-(diaminomethylideneamino)propyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos |
lys-conopressin, lymnaea stagnalis |
oxytocin, 2-l-phenylalanine-4-l-arginine-8-l-lysine- |
lys-conopressin g |
lys-conopressin |
lymnaea conopressin |
SCHEMBL15511399 |
glycinamide,l-cysteinyl-l-phenylalanyl-l-isoleucyl-l-arginyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysyl-,cyclic (1(r)6)-disulfide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (68.75) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 16.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (16.59) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.56%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (94.44%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |